Diabetic Eye Disease 101: The Science of Blood Sugar and Vision

Nov 27, 2020 | Eye Health | 0 comments

November is National Diabetes Awareness Month and a good time to talk about some of the complexities of the disease that affects the lives of many Americans. Diabetes is found in over 10% of the population in the US. 

A person with diabetes will experience high blood sugar levels (hyperglycemia). The glucose from the food we eat needs to be transferred from the bloodstream into the cells to provide energy. A hormone called insulin usually assists this transfer. A diabetic person either produces none or not enough of this crucial hormone — and hyperglycemia can occur.

There are complications to having high blood sugar levels, and it can affect many body functions. One function that can be particularly affected is your vision. This blog will go over some of the eye diseases associated with diabetes — the causes, symptoms, and some common treatments.

Diabetic Retinopathy

The most prevalent diabetic eye disease is diabetic retinopathy. This disease occurs when the blood vessels in the retina do not receive enough nutrients over time due to chronic hyperglycemia. The retina is the film at the back of the eye that contains millions of cells that receive the light your eye takes in. These cells then transfer that information via the optic nerve to your brain for processing. This process requires a lot of energy!

There are three main stages of diabetic retinopathy.

Stage 1: Diabetes without retinopathy

 

The first stage is called diabetes without retinopathy. In this stage, cells on the blood vessels called pericytes are damaged. Pericytes help regulate blood flow and the loss of pericytes mean that walls of the blood vessels will start to bulge. The patient will often experience no symptoms in the first stage of retinopathy.

The best way to manage the first stage is to:

  • Maintain good control of blood sugar levels

  • Go to a yearly eye exam to monitor for progression to the second stage

Stage 2: Nonproliferative retinopathy

 

The second stage is nonproliferative retinopathy and usually begins 15-25 years after a diabetes diagnosis. The weakened blood vessel walls from the lack of pericyte cells will continue to bulge, creating microaneurysms. These appear as small red dots in the retina in an eye exam. Blood vessels can also leak blood, proteins, and lipids, causing hard exudates to form which appear as yellow/white “cotton wool” spots. These red microaneurysms and yellow/white hard exudates observed in an eye exam are often the first signs of diabetic retinopathy that your eye doctor will detect. This stage is sometimes asymptomatic for the patient and can last a long time before progressing to the third stage.

To manage this stage:

  • Continue to maintain good control of blood sugar levels

  • Go to a yearly eye exam to monitor progression

  • Maybe start taking Anti-VEGF medication (see below)

Stage 3: Proliferative retinopathy

 

The third and most severe stage is proliferative retinopathy. When retinopathy becomes proliferative, there is a complete lack of oxygen to retina cells. The retina will try to compensate by producing vascular endothelial growth factor (VEGF), a signal protein that produces new blood vessels. These new blood vessels are abnormal, small, and weak. They can easily burst and cause bleeding in the eye. Patients in this stage often experience blind spots or floaters as symptoms. Hemorrhaging in the eye can cause sudden vision loss and requires immediate care.

The treatment for this stage is:

  • Laser photocoagulation — a procedure that uses a focused laser to stop blood vessels from bleeding and to stop new blood vessels from being formed

  • Anti-VEGF — a medication used to stop VEGF proteins from creating new blood vessels

This stage needs to be closely monitored by your eyecare provider!

Photo courtesy of the AOA

Other Diabetic Eye Diseases

Diabetic Macular Edema

Even if you aren’t experiencing vision loss, it’s important for diabetic patients to go in for a yearly diabetic eye exam because diabetic macular edema (DME) can occur at any stage of diabetic retinopathy.

As the name suggests, this disease occurs in the macula, the center of the retina which processes sharp, color images. When DME occurs, blood vessels leak blood and fatty tissues into the macula, which then swells and causes the vision to blur. The vision lost from DME can be permanent.

Cataracts

 

Diabetes can also increase your risk of developing cataracts. Hyperglycemia can cause glucose to be converted to Sorbitol, a sugar alcohol. When Sorbitol accumulates, the lens of the eye becomes swollen and opaque and this leads to cataracts. To learn more about cataracts, see our previous article 5 Common Myths about Cataracts.

Glaucoma

 

The risk of developing open-angle glaucoma is also increased with diabetes. This type of glaucoma occurs when the fluid in the eyes cannot drain and the resultant intraocular pressure damages the optic nerve and peripheral vision is diminished. To learn more about glaucoma, stay tuned for our upcoming articles Do I have Glaucoma? The Warning Signs and What is Intraocular Pressure? coming soon!

The most important take-away is to schedule your annual eye exam, especially if you are diabetic! Be sure to specifically request a diabetic eye exam if you are scheduling with a new eyecare provider.

Eye health education is part of our mission at Nanodropper. Learn how you can take back control of your eye health, one drop at a time.

Why do I need to attend the onboarding webinar?

 

In the onboarding webinar you’ll learn essential information about using Nanodropper safely and effectively. While the device is simple to use, proper technique is key to ensuring you receive its full benefits. You’ll also have the opportunity to ask our team any questions you may have. We look forward to helping you get started with confidence!

Why do I need to take the onboarding survey?

 

By completing this survey, you’ll provide important information about your current medications, such as cost, bottle usage, and side effects. This helps Nanodropper and MedOne evaluate the program’s success and ensure this benefit can continue to support patients like you in the future. Thank you for your valuable input!

Meet Seema

Scottsdale, AZ

Seema is the Chief Strategy Officer of Kore Power where she leads Strategy and Corporate Development. She previously founded ForeOptics, a management consulting firm specializing in complex transformations; change leadership techniques; and operational turnarounds to help organizations accelerate value capture and unlock business growth and potential. She exhibits deep expertise in designing, streamlining, and managing complex global supply chains and operations.

Meet Chris

Phoenix, AZ

Chris is the Managing Director of Xcellerant Ventures, and CEO of Yoo & Co Accelerators. He is a serial entrepreneur, angel investor, venture capitalist, educator, and developer of new value creation in the Healthcare & Life Sciences industry. Chris has deep knowledge in disruptive technologies and is passionate about seeing great research innovations quickly become fundamental improvements to how we understand health and treat disease.

Meet Katey

Oklahoma City, OK

Katey Letzkus earned her Bachelors in Journalism from Oklahoma State University and is passionate about helping clinics grow and achieve their goals! Through her 14 years of medical sales experience, she has received multiple honors for her work with Plastic Surgeons, Prosthodontists, Oral Surgeons and large med spas to grow their businesses. Her primary goal is to ensure patients with financial hardships receive the eye medications they need while helping businesses save money.

Meet Andrew

New York City, NY

Andrew received his undergraduate degree in Sociology from Temple University in Philadelphia. During his studies, he gained unique insight into various socioeconomic inequities that are affecting our local and global communities. Andrew leverages his diverse work experience to help foster new partnerships and to strengthen existing connections with both patients and eye care professionals.

Meet Brooke

Philadelphia, PA

Brooke received her undergraduate degree in communications and Master’s degree in Public Administration from Florida Gulf Coast University. Brooke was formerly the Executive Director for a Southwest Florida nonprofit offering teen girls leadership and fitness programming. Using her extensive leadership, management, travel and operations experience, Brooke seeks to continue developing new and effective ways to grow the company. Brooke is also leading the charge to build new nonprofit partnerships and expand our mission.

Meet Alena

Washington State

Alena received her degree in chemistry from Western Washington University, fostering her love for all things science and numbers. She uses her analytical background to dive into the data, finding ways to better develop connections with eyecare providers to improve the accessibility and affordability of healthcare.

Meet Robbie

Rochester, MN

Robbie is an entrepreneur and award-winning journalist with a background in marketing and communications. He has contributed to The New York Times, Florida Weekly, and Mayo Clinic's education shield, and was once co-founder and executive editor of a news company in his hometown of Naples, Fla.

Meet Jenny

Tacoma, WA

Jenny’s inquisitive mind and entrepreneurial roots led her to co-found Nanodropper. She recently completed her PhD in pharmacology at the University of Washington, and she has scientific research experience at top academic institutions, including her alma mater Brown University, Harvard Medical School, and UW.

Meet Mackenzie

Denver, CO

Mackenzie is a device design engineer who earned her master’s degree in bioengineering with a focus on technology commercialization from the University of Washington. She is passionate about designing and commercializing solutions to address current healthcare problems, especially to help close health equity gaps.   

Meet Elias

Rochester, MN

Elias is a mechanical engineer specializing in design and prototyping. He loves being involved with startups because they challenge him in new and exciting ways. His broad background includes projects with SpaceX, Spacelabs Healthcare, Kestra Medical Technologies, and McKinstry. His passion is within the biomedical industry, making advances in medical devices.

Meet Allisa

Rochester, MN

Allisa is a physician-entrepreneur and inventor who received her MD from the Mayo Clinic. With a background in Clean Tech, neuroscience, and harm reduction, she is a thought leader in the field of value-based innovation and the visionary behind Nanodropper. Allisa's patient-centered mindset drives Nanodropper's mission. 

Skip to content